Search | IOVS | ARVO Journals

View

Showing 1 – 4 of 4

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

In vitro bio-functional profiles and in vivo outcome of α1,3-galactosyltransferase gene-knockout miniature pig-to-nonhuman primate corneal xenotransplantation

Mee Kum Kim; Chang Ho Yoon; Se Hyun Choi; Hyun Ju Lee; Hee Jung Kang; Jong Min Kim; Chung-Gyu Park; Kimyung Choi; Hyunil Kim; Curie Ahn; Hyuk Jin Choi

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6312. doi:

ARVO Annual Meeting Abstract July 2018

In vitro characteristics and in vivo outcome of α1,3-galactosyltransferase gene-knockout miniature pig cornea in full-thickness corneal xenotransplantation using nonhuman primate

Chang Ho Yoon; Se Hyun Choi; Hyun Ju Lee; Hong Pyo Kim; Hee Jung Kang; Jong Min Kim; Hyuk Jin Choi; Chung-Gyu Park; Kimyung Choi; Hyunil Kim; Curie Ahn; Mee Kum Kim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1332. doi:

ARVO Annual Meeting Abstract June 2017

Comparative efficacy of anti-CD40 antibody mediated-costimulation blockade and anti-CD20 antibody/tacrolimus treatment on the survival of full thickness xenocorneal transplantation in non-human primates

Mee Kum Kim; Chang Ho Yoon; Jaeyoung Kim; Hyun Ju Lee; Hyunsang Kwon; Hee Jung Kang; Chung-Gyu Park; Eung-Soo Hwang; Won Ryang Wee

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):974. doi:

ARVO Annual Meeting Abstract September 2016

Long term Effect of anti-CD40 antibody treatment on the survival of corneal xenotransplantation

Mee Kum Kim; Jaeyoung Kim; Dong Hyun Kim; Hyuk Jin Choi; Hyun Ju Lee; Hyun Jeong Jeong; Hee Jung Kang; Chung-Gyu Park; Won Ryang Wee

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1440. doi:

Advertisement